(Q37074142)

18 August 2017

1 reference

title

Metabolomics in biomarker discovery: future uses for cancer prevention (English)

1 reference

18 August 2017

0 references

1 reference

3

John A Milner

1 reference

18 August 2017

Young S Kim

1

1 reference

18 August 2017

Padma Maruvada

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

4

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

93-102

1 reference

Functional genomics: lessons from yeast

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolomic approaches to phenotype characterization and applications to complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Genetic determinants of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Dietary components impact histone modifications and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

The new field of epigenomics: implications for cancer and other common disease research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Diet and cancer: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

The impact of genomics and proteomics in the clinic: functional genetic polymorphisms and their value in response and toxicity prediction in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Genetic etiology of hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Targeted metabolomics analysis of Campylobacter coli VC167 reveals legionaminic acid derivatives as novel flagellar glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Tumor-associated antigens and biomarkers in cancer and immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

NMR-based metabolomics approach to target biomarkers for human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolomics: available results, current research projects in breast cancer, and future applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Development of biomarkers based on diet-dependent metabolic serotypes: characteristics of component-based models of metabolic serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolic fingerprinting as a diagnostic tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

FTMS and TOF/TOF mass spectrometry in concert: identifying peptides with high reliability using matrix prespotted MALDI target plates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Characterizing the phospholipid profiles in mammalian tissues by MALDI FTMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

High-resolution magic angle spinning 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Early detection of graft failure using the blood metabolic profile of a liver recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Identification of mobile cholesterol compounds in experimental gliomas by (1)H MRS in vivo: effects of ganciclovir-induced apoptosis on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Glycolysis in cancer: a potential target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Akt stimulates aerobic glycolysis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Polyamines and prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Ornithine decarboxylase (ODC) expression pattern in human prostate tissues and ODC transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Hypoxia signalling in cancer and approaches to enforce tumour regression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Hypoxia: a key regulator of angiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

A metabolomics perspective of human brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolomic analysis and signatures in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Application of biofluid 1 H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.93

Reliable profile detection in comparative metabolomics

21 January 2018

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1089/OMI.2007.0006

Identifiers

DOI

10.2217/14796694.4.1.93

1 reference

18 August 2017

1 reference